Pages that link to "Q24675069"
Jump to navigation
Jump to search
The following pages link to In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate (Q24675069):
Displaying 50 items.
- Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats (Q24602751) (← links)
- Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat (Q24651957) (← links)
- Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 (Q28236198) (← links)
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease (Q28287100) (← links)
- Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons (Q28395100) (← links)
- 5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. (Q30491992) (← links)
- Semi-micro liquid chromatography of aromatic amino acid metabolites using isocratic elution and column switching. (Q31109222) (← links)
- Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidation (Q31863600) (← links)
- Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data (Q33706897) (← links)
- Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134). (Q33930185) (← links)
- E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. (Q34111024) (← links)
- Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist (Q34117799) (← links)
- 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. (Q34138219) (← links)
- Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders (Q34177643) (← links)
- Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. (Q34247123) (← links)
- The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats (Q34271590) (← links)
- Descending control of pain (Q34659433) (← links)
- Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex (Q34699454) (← links)
- The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis (Q34730873) (← links)
- Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task (Q34847404) (← links)
- Alzheimer's disease and age-related memory decline (preclinical) (Q35041190) (← links)
- The neurobiology and control of anxious states (Q35202929) (← links)
- Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders (Q35810041) (← links)
- 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms (Q36346938) (← links)
- Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. (Q37954123) (← links)
- 5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives (Q38027891) (← links)
- Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment. (Q38683808) (← links)
- Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer's disease (Q39158422) (← links)
- Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain (Q41307502) (← links)
- Automated capillary liquid chromatography for simultaneous determination of neuroactive amines and amino acids (Q42050601) (← links)
- Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist (Q42436868) (← links)
- Effects of serotonin (5-HT)6 receptor ligands on responding for cocaine reward and seeking in rats (Q42754412) (← links)
- A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides. (Q43026448) (← links)
- Signalling pathways associated with 5-HT6 receptors: relevance for cognitive effects (Q43279624) (← links)
- 5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides (Q43581196) (← links)
- Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT(6) receptor (Q43764117) (← links)
- 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine (Q43862483) (← links)
- Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia (Q43913079) (← links)
- Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists (Q43981464) (← links)
- An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. (Q44092155) (← links)
- Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease (Q44626972) (← links)
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism (Q45145553) (← links)
- Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis (Q45776602) (← links)
- Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved. (Q45977455) (← links)
- Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse (Q46505770) (← links)
- The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. (Q46547641) (← links)
- Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior (Q47587262) (← links)
- Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light–dark cycle (Q48343708) (← links)
- 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice (Q50965059) (← links)
- Idalopirdine for Alzheimer's disease: written in the stars. (Q53357594) (← links)